A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis Academic Article uri icon

Overview

MeSH Major

  • Antirheumatic Agents
  • Arthritis, Rheumatoid
  • Immunoglobulin G
  • Methotrexate
  • Receptors, Tumor Necrosis Factor

abstract

  • As compared with oral methotrexate, subcutaneous [corrected] etanercept acted more rapidly to decrease symptoms and slow joint damage in patients with early active rheumatoid arthritis.

publication date

  • November 30, 2000

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1056/NEJM200011303432201

PubMed ID

  • 11096165

Additional Document Info

start page

  • 1586

end page

  • 93

volume

  • 343

number

  • 22